Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
388 hedge funds and large institutions have $7.52B invested in Amedisys in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 136 increasing their positions, 151 reducing their positions, and 50 closing their positions.
10% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 151
1.93% less ownership
Funds ownership: 88.71% → 86.78% (-1.9%)
2% less funds holding
Funds holding: 396 → 388 (-8)
10% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 50
12% less capital invested
Capital invested by funds: $8.52B → $7.52B (-$996M)
15% less call options, than puts
Call options by funds: $33.9M | Put options by funds: $40M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$100M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$74.3M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$65.5M |
| 4 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$50.4M |
| 5 |
BlackRock
New York
|
+$34.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$234M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$42.3M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$41.9M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$41.3M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$32.7M |
AMED Hedge Fund Activity: Q1 2021 in Review
388 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q1 2021, worth a combined $7.52B — down 12% from $8.52B a quarter earlier.
Sellers outnumbered buyers: 50 funds closed out of AMED and 45 opened new positions — a net loss of 5 holders — while 151 trimmed existing stakes and 136 added.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $100M. The largest seller was Wellington Management Group, cutting an estimated $234M.
- 388 institutional investors held Amedisys (AMED) as of Q1 2021, down from 396 in Q4 2020.
- Funds reported $7.52B of Amedisys stock for Q1 2021, down 12% quarter-over-quarter.
- 45 funds opened new Amedisys positions in Q1 2021 and 50 closed out, a net change of -5 holders.
- The largest Amedisys buyer in Q1 2021 was Thrivent Financial for Lutherans, an estimated $100M added.
- The largest Amedisys seller in Q1 2021 was Wellington Management Group, an estimated $234M sold.
Based on aggregated 13F filings for Q1 2021.